课题基金 / 基金详情

Hign Performance MEMS Deformable Mirror for Adaptive Optics Retinal Imaging

Hign Performance MEMS Deformable Mirror for Adaptive Optics Retinal Imaging
用于自适应光学视网膜成像的高性能 MEMS 可变形镜
批准号:
7498432
负责人:
Michael Albert Helmbrecht
金额:
$33.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2010-08-31
关键词:
AffectAgeAge related macular degenerationAirAreaArtsAstronomyAuditoryAwardBe++ elementBedsBerylliumBiomedical EngineeringBlindnessBlurCaliberCaringCellsCellular StructuresClassificationClinicalCollaborationsComputer Systems DevelopmentComputersConditionContact LensesContractsCountCoupledCustomDailyDepthDetectionDevelopmentDevicesDiabetic RetinopathyDiagnosisDiseaseElectronicsElementsEngineeringExhibitsEyeEye diseasesFailureFinite Element AnalysisFloodsFreedomFrequenciesFundusGeneral PopulationGlaucomaGoalsGrantHandHeartHousingHumanImageImageryImaging TechniquesIndividualIndustryInvasiveIrisLaboratoriesLaboratory ResearchLaser SurgeryLasersLettersLightMaintenanceManufacturer NameMarketingMeasuresMechanicsMedicineMembraneMissionModalityNeural PathwaysNumbersOperative Surgical ProceduresOphthalmologyOphthalmoscopesOptical Coherence TomographyOpticsOutputPatientsPerformancePhasePhotoreceptorsPlayPopulationPopulation StudyPositioning AttributeProcessProductionPropertyPupilQuality of lifeRangeReportingResearchResearch PersonnelResearch SubjectsResolutionRetinaRetinalRetinal ConeRetinal DiseasesRoleScanningSemiconductorsShapesSideSignal TransductionSiteSmall Business Funding MechanismsSmall Business Innovation Research GrantStandards of Weights and MeasuresStrokeStructureSurfaceSystemTechniquesTechnologyTestingTodayUnited StatesUniversitiesVisionVisualVisual AcuityVisual PathwaysWorkadaptive opticsbasecellular imagingcommercializationcomputerized data processingcostdesigndesign and constructionexperiencefallsfeedingfightingfootimprovedin vivoinnovative technologiesinstrumentinstrumentationlensliquid crystalmillimeternext generationnovelperformance testsprogramsprototyperelating to nervous systemresearch studyresponseretinal rodssensorsizesomatosensorytechnology developmenttoolvision science

项目摘要

项目成果

Michael Albert Helmbrecht的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Iris AO is developing exciting technologies that enable in vivo cellular-level retinal imaging. The cutting-edge adaptive-optics (AO) systems Iris AO develops increases the axial and transverse resolution of retinal images 5 fold. AO is used to correct for the optical aberrations in the eye that drastically reduce the resolution of conventional retinal images. Deformable mirrors (DM), the enabling component in AO systems, correct aberration by changing shape to compensate for the aberrations. This Phase II SBIR is dedicated to building advanced Microelectromechanical Systems (MEMS) DMs for clinical retinal-imaging systems. Imaging systems with AO exist in but a few cutting edge research laboratories throughout the world. In all of these systems, the most limiting aspect is the DM. These systems use DMs originally designed for telescopes or other applications because these are all that are available. This SBIR will bring DMs specifically designed for retinal imaging into the hands of researchers and then into clinical retinal imaging systems. Developing clinical-ready DMs will bring the benefits of these advanced imaging techniques to the general population. Iris AO's comprehensive expertise from DM manufacturing to building AO retinal-imaging systems for daily use in studying retinal diseases at the cellular-level will drive a revolution in advanced imaging techniques. By bringing AO out of the lab and into the clinical setting, this technology will have profound benefits. Iris AO's goals parallel the NEI mission of gaining a better understanding of visual function and fighting debilitating eye diseases. Iris AO engineers have helped pioneer studies in early disease detection by looking at the retina with the unprecedented resolution afforded by AO. This proposal directly meets objectives laid out in the NEI National Plan by developing a critical component in AO systems that will be used in AO-equipped SLO and OCT systems. This research will develop the DM over two iterations, refining the manufacturing each step of the way. Finite element analysis, performance testing, and failure studies will feed into the design to create robust mirrors. The development will focus on clinically valuable mirrors by meeting the required correction performance and solving practical issues necessary to bring AO into the clinical setting. After the mirror is built and tested in an AO test bed, it will be integrated into an existing AO retinal imaging system to image photoreceptors. This exciting high-performance technology will enable in vivo imaging of cellular structure to be done on the general populace instead of hand-picked research subjects as is the practice today. Research from this SBIR will enable a powerful new tool for early retinal disease detection and better understanding of visual function. The resulting technology puts the ability to observe into the retina at the cellular level into the hands of clinicians, thereby allowing them to see the start of a retinal disease before debilitating damage has been done.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hign Performance MEMS Deformable Mirror for Adaptive Optics Retinal Imaging
  • 批准号:
    7903673
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2004
  • 负责人:
    Michael Albert Helmbrecht
  • 依托单位:
Deformable Mirror for Adaptive Optics Retinal Imaging
  • 批准号:
    6742040
  • 项目类别:
  • 资助金额:
    $9.99万
  • 财政年份:
    2004
  • 负责人:
    Michael Albert Helmbrecht
  • 依托单位:
Hign Performance MEMS Deformable Mirror for Adaptive Optics Retinal Imaging
  • 批准号:
    7273782
  • 项目类别:
  • 资助金额:
    $41.9万
  • 财政年份:
    2004
  • 负责人:
    Michael Albert Helmbrecht
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: